双开窗医生改良支架全主动脉弓修复50例
单中心回顾性分析50例全腔内主动脉弓修复患者,采用双开窗医生改良支架(PMEG),近端大开窗覆盖头臂干和左颈总动脉,远端小开窗针对左锁骨下动脉(LSA)且仅LSA置入支架。技术成功率94%,30天死亡率2%,中位随访16个月无开放转换、主动脉破裂、截瘫或逆行夹层。
要点
- 双开窗PMEG全腔内主动脉弓修复可行有效,避免解剖外旁路手术。
- 头臂干不置入支架未增加内漏或治疗失败,且卒中风险低于替代策略。
- LSA开窗预置导丝技术改良后技术成功率达100%。
核心结论
- 双开窗PMEG用于TEVAR全腔内主动脉弓修复可行有效,避免解剖及解剖外血运重建。
研究设计与样本
- 单中心回顾性分析前瞻性收集数据,2017年1月至2019年10月共50例接受TEVAR的患者。
- 开窗设计:近端较大开窗纳入头臂干和左颈总动脉,远端较小开窗针对左锁骨下动脉(LSA)。
- 仅LSA开窗置入支架。
主要发现
- 支架修改中位时间26±6分钟;50例中41例男性,平均年龄68±11.5岁。
- 技术成功率总体94%(47/50),采用LSA开窗预置导丝技术改良后为100%(28/28)(P<.05)。
- 30天死亡率2%(n=1);2例(4%)轻微卒中完全恢复;1例(2%)IB型内漏,2例(4%)LSA来源II型内漏。
- 4例(8%)需再干预:1例因IB型内漏,3例因入路相关并发症;所有主动脉上干通畅。
- 平均随访16±8.3个月,无开放手术转换、主动脉破裂、截瘫或逆行夹层。
临床怎么用
- 双开窗PMEG可用于全腔内主动脉弓修复,避免解剖外旁路手术。
- 头臂干不置入支架未增加内漏或治疗失败,且卒中风险较低。
- LSA开窗预置导丝技术可提高技术成功率。
局限性
- 单中心回顾性分析,样本量50例,随访时间有限(平均16±8.3个月)。
- 密封持久性和长期耐久性需长期随访研究评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Our aim was to evaluate the early- and medium-term outcomes of using double fenestrated physician-modified endovascular grafts (PMEGs) for total endovascular aortic arch repair. METHODS: The present single-center retrospective analysis of prospectively collected data included 50 patients from January 2017 through October 2019, who had undergone thoracic endovascular aortic repair (TEVAR). The fenestrations were a proximal larger fenestration that incorporated the brachiocephalic trunk and left common carotid artery and a distal smaller fenestration for the left subclavian artery (LSA). Only the LSA fenestration was stented. RESULTS: The median duration for stent graft modification was 26 ± 6 minutes. Of the 50 patients, 41 were men. The mean patient age was 68 ± 11.5 years. The indications for treatment included degenerative aortic arch aneurysm (n = 17), dissecting aortic arch aneurysm after type A dissection (n = 13), type B dissection (n = 13), aortic ulcer (n = 3), and other pathologies (n = 4). The technical success rate was 94% (47 of 50) overall, and 100% (28 of 28) after a technical modification incorporating a preloaded guide wire for the LSA fenestration (P < .05). The 30-day mortality was 2% (n = 1). Two patients (4%) had a minor stroke with full recovery. One patient (2%) had a type IB and two patients (4%) had a type II endoleak from the LSA. Four patients (8%) required reintervention: one because of a type IB endoleak and three because of access-related complications. All supra-aortic trunks were patent. During a mean follow-up of 16 ± 8.3 months, no conversions to open surgical repair were required and no aortic rupture, paraplegia, or retrograde dissection occurred. CONCLUSIONS: Using double fenestrated PMEGs for TEVAR is both feasible and effective for total endovascular aortic arch repair, avoiding the need for anatomic and extra-anatomic surgical revascularization. The absence of brachiocephalic trunk stenting was not associated with endoleaks or treatment failure and resulted in a lower stroke risk than alternative strategies. The midterm results suggest that stenting of the brachiocephalic trunk and right common carotid artery might not be necessary for a large proportion of patients undergoing total endovascular aortic arch repair. The persistence of the seal and ongoing durability require assessment in studies with long-term follow-up data available.
引用
- Chassin-Trubert L, Gandet T, Lounes Y, et al. Double fenestrated physician-modified stent-grafts for total aortic arch repair in 50 patients. J Vasc Surg. 2020. PMID: 33227376. doi:10.1016/j.jvs.2020.09.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。